Novo Nordisk: The "Pill Effect" Takes Off – My Top Pick Delivers!
My defensive growth stock favorite is already up nearly 20% this year!
Analysts are increasingly confirming my thesis!
Reading Time: 2 minutes
My defensive growth favorite is fully showcasing its strengths: The stock is up almost 20% since the beginning of the year, and today's news reinforces exactly the scenario I have bet on. 1) Analyst Endorsement Not only the market is reacting, the professionals are following suit: Berenberg has raised the price target to 415 DKK today and confirmed the rating "Buy" . Reason: The analysts see early traction with the oral Wegovy variant and thus precisely the demand lever that makes the setup so exciting. 2) Fundamental Trigger: The "Injection...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
